Rebecca Knibb

Dr. Rebecca Knibb

School of Life & Health Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, UK
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2010 in Allergy
Verified
Journal Article
Open access
PDF file
ACA. J. Cummings
A. J. Cummings
Rebecca KnibbRebecca Knibb
Rebecca Knibb
RKR. M. King
R. M. King
JLJane S Lucas
Jane S Lucas
To cite this article: Cummings AJ, Knibb RC, King RM, Lucas JS. The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review. Allergy 2010; 65: 933–945. Food allergy affects 6% of children but there is no cure, and strict avoidance of index allergens along with immediate access to rescue medication is the current best management. With specialist care, morbidity from food allergy in children is generally low, and mortality is very rare. However, there is strong evidence that food allergy and food hypersensitivity has an impact on psychological distress and on the quality of life (QoL) of children and adolescents, as well as their families. Until recently, the measurement of QoL in allergic children has proved difficult because of the lack of investigative tools available. New instruments for assessing QoL in food allergic children have recently been developed and validated, which should provide further insights into the problems these children encounter and will enable us to measure the effects of interventions in patients. This review examines the published impact of food allergy on affected children, adolescents and their families. It considers influences such as gender, age, disease severity, co‐existing allergies and external influences, and examines how these may impact on allergy‐related QoL and psychological distress including anxiety and depression. Implications of the impact are considered alongside avenues for future research.

23 February 2009 in Allergy
Verified
Journal Article
Closed access
PDF file
RKR. M. King
R. M. King
Rebecca KnibbRebecca Knibb
Rebecca Knibb
JHJ. O’b. Hourihane
J. O’b. Hourihane

2 June 2020 in Allergy
Verified
Journal Article
Closed access
PDF file
IAIoana Agache
Ioana Agache
CACezmi A. Akdis
Cezmi A. Akdis
MAMubeccel Akdis
Mubeccel Akdis
GCGiorgio Walter Canonica
Giorgio Walter Canonica
TCThomas B Casale
Thomas B Casale
MJMarek Jutel
Marek Jutel

20 November 2020 in Allergy
Verified
Journal Article
Open access
PDF file
JLJay A. Lieberman
Jay A. Lieberman
RGRuchi S Gupta
Ruchi S Gupta
Rebecca KnibbRebecca Knibb
Rebecca Knibb
THTmirah Haselkorn
Tmirah Haselkorn
STStephen Tilles
Stephen Tilles
GPGuillaume Pouessel
Guillaume Pouessel
Peanut allergy (PA) currently affects approximately 2% of the general population of Western nations and may be increasing in prevalence. Patients with PA and their families/caregivers bear a considerable burden of self‐management to avoid accidental peanut exposure and to administer emergency medication (adrenaline) if needed. Compared with other food allergies, PA is associated with higher rates of accidental exposure, severe reactions and potentially fatal anaphylaxis. Approximately 7%–14% of patients with PA experience accidental peanut exposure annually, and one‐third to one‐half may experience anaphylaxis, although fatalities are rare. These risks impose considerably high healthcare utilization and economic costs for patients with PA and restrictions on daily activities. Measures to accommodate patients with PA are often inadequate, with inconsistent standards for food labelling and inadequate safety policies in public establishments such as restaurants and schools. Children with PA are often bullied, resulting in sadness, humiliation and anxiety. These factors cumulatively contribute to significantly reduced health‐related quality of life for patients with PA and families/caregivers. Such factors also provide essential context for risk/benefit assessments of new PA therapies. This narrative review comprehensively assessed the various factors comprising the burden of PA.

14 June 2019 in Allergy
Verified
Journal Article
Open access
PDF file
RMRosan Meyer
Rosan Meyer
ALAdriana Chebar Lozinsky
Adriana Chebar Lozinsky
DFDavid M. Fleischer
David M. Fleischer
MVMario C. Vieira
Mario C. Vieira
GTGeorge Du Toit
George Du Toit
CVCarina Venter
Carina Venter
It is well‐established that food proteins, such as egg, soya, cow's milk and wheat, are detectable in breastmilk for many hours or days after ingestion. Exposure to these proteins is important to the process of developing tolerance but can also sometimes elicit IgE‐mediated and non–IgE‐mediated allergic symptoms in breastfed infants. Non–IgE‐mediated allergy, outside of food protein‐induced allergic proctocolitis and eosinophilic oesophagitis, is not well understood, leading to variations in the diagnosis and management thereof. A primary objective of the European Academy for Allergy and Clinical Immunology is to support breastfeeding in all infants, including those with food allergies. A Task Force was established, to explore the clinical spectrum of non–IgE‐mediated allergies, and part of its objectives was to establish diagnosis and management of non–IgE‐mediated allergies in breastfed infants. Eight questions were formulated using the Patient, Intervention, Comparison, Outcome (PICO) system and Scottish Intercollegiate Guideline Network (SIGN) criteria for data inclusion, and consensus was achieved on practice points through the Delphi method. This publication aims to provide a comprehensive overview on this topic with practice points for healthcare professionals.

14 January 2010 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
ACAmanda J. Cummings
Amanda J. Cummings
Rebecca KnibbRebecca Knibb
Rebecca Knibb
MEMichel Erlewyn-Lajeunesse
Michel Erlewyn-Lajeunesse
RKRosemary M. King
Rosemary M. King
GRGraham Roberts
Graham Roberts
JLJane S Lucas
Jane S Lucas